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Eleven  compounds,  12-oxo-phytodienoic  acid (1),  persicogenin  (2),  eriodictyol  3′,4′,7-trimethyl  ether
(3),  phytol  (4),  spathulenol  (5),  4-hydroxycinnamic  acid (6),  onopordin  (7), 5,8,4′-trihydroxy-7,3′-
dimethoxyﬂavone  (8),  quercetin  (9),  jaceosidin  (10),  and  8-hydroxyluteolin  (11), were  isolated  from  an
ethanol  extract  of  Lantana  balansae  Briq.,  Verbenaceae,  that  was found  to possess  antileishmanial  activ-
ity.  The  structures  of  the compounds  were  determined  by NMR  spectroscopy  and  HR  mass  spectrometry,
and  1, 2, 3, 7, 8 and  9  were  investigated  for  antiprotozoal  activity  toward  promastigotes  of Leishmanialavonoids
antana balansae
eishmania amazonensis
. braziliensis
2-oxo-phytodienoic acid
amazonensis  and  Leishmania  braziliensis.  Compound  1  was  shown  to be  the most potent,  with  the IC50
values  2.0 M toward  L.  amazonensis  and  0.68  M toward  L.  braziliensis,  although  less  potent  than  the
positive  control  Amphotericin  B. All compounds  have  been  reported  previously,  but  this  is  the  ﬁrst  report
of  the  isolation  of  a cyclopentenone  fatty  acid  (1) and ﬂavanones  (2 and  3) from  a  Lantana  species.
© 2016  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
The knowledge of the traditional uses of plants to treat dif-
erent conditions has not only been helpful in the search for
ew biologically active compounds, but also contributed to pre-
erve the information obtained directly from the people living in
solated rural communities. Based on such knowledge, extensive
hytochemical studies of different Lantana species, particularly L.
amara, have led to the identiﬁcation of lantadenes (pentacyclic
riterpenoids), ﬂavonoids and phenylpropanoids as the charac-
eristic secondary metabolites of this species. The biological and
harmacological evaluation of crude extracts, essential oils and
solated compounds have shown that they possess a broad range
f biological activities, for example antiprotozoal (antiplasmodial,
ntimalarial, leishmanicidal), antiviral, antioxidant, antiprolifera-
ive and cytotoxic activities (Ghisalberti, 2000; Grace-Lynn et al.,
012; Sousa and Costa, 2012).
Lantana balansae Briq., Verbenaceae, is a perennial shrub with a
ungent odor that grows in the mountain region of Cochabamba,
olivia, where it is locally known as “k’ichita”. An infusion of
resh leaves of L. balansae is used in the traditional medicine to
reat digestive disorders and muscle spasms (personal communi-
ation with local people where the plant was collected). Previous
∗ Corresponding author.
E-mail: olov.sterner@science.lu.se (O. Sterner).
http://dx.doi.org/10.1016/j.bjp.2015.11.007
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorastudies of L. balansae have reported the antimicrobial activity of
the methanol extract (Salvat et al., 2004) and the chemical com-
position of its essential oil (De Viana et al., 1973; Sena Filho et al.,
2012). As part of our search for bioactive secondary metabolites
from the native ﬂora of Bolivia, an ethanol extract of L. balansae was
assayed for leishmanicidal activity toward Leishmania amazonen-
sis and Leishmania braziliensis. As the extract displayed signiﬁcant
activity toward both species of Leishmania it was selected for a more
detailed study. Herein, we  wish to report the secondary metabolites
isolated from L. balansae as well as the leishmanicidal activities of
six metabolites.
Materials and methods
General
1D and 2D NMR  spectra were recorded at room temperature
with a Bruker Avance II 400 or a Bruker Avance 500 spectrome-
ter. The chemical shifts (ı) are reported in ppm relative to solvent
signals (ıH 7.16 and ıC 128.0 for C6D6, ıH 2.05 and ıC 206.0 for
acetone-d6, and ıH 2.49 and ıC 39.5 for DMSO-d6), while the cou-
pling constants (J) are given in Hz. HR-ESI-MS experiments were
performed with a Waters Q-TOF Micro system spectrometer, using
H3PO4 for calibration and as internal standard. Vacuum liquid chro-
matography (VLC) separations were carried out on Merck silica gel
60G (Merck), while column chromatography (CC) was  performed
using silica gel 60 (230–400 mesh, Merck) and gel permeation on
 Ltda. All rights reserved.
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ephadex LH-20 (GE-Healthcare). Analytical TLC plates were visu-
lized with UV light at 254 nm and spraying with vanillin followed
y heating. Preparative TLC (PTLC) was run on 20 cm × 20 cm glass-
oated plates (1 mm thickness, Analtech).
lant material
The aerial parts of Lantana balansae Briq., Verbenaceae, were
ollected near Independencia, Cochabamba, Bolivia at coordinates
7◦11.17′ S 66◦43.58′ W and an elevation of 2789 m.  Voucher spec-
mens, taxonomically identiﬁed by Lic. Modesto Zárate, are kept at
Herbario Forestal Martín Cárdenas”, Cochabamba, under accession
umber MZ-3946.
xtraction and isolation
The air-dried and ground leaves and ﬂowers of L. balansae
1308 g) were extracted twice at room temperature by macera-
ion in 95% EtOH for 48 h. After ﬁltration the combined solutions
ere concentrated under reduced pressure to yield 136.6 g of a
ark residue. The crude organic extract was suspended in a mix-
ure of H2O:MeOH (9:1, v/v, 500 ml)  and extracted four times with
00 ml  hexane followed by the extraction with ethyl acetate (four
imes, 500 ml). After evaporation of the solvents, the two fractions
23.5 and 43.6 g, respectively) were fractionated. VLC chromatog-
aphy (hexane:CH2Cl2 1:0 to 0:1) of the hexane extract yielded ten
ajor fractions (A–J). Fraction E (3.0 g) was subjected to VLC (hep-
ane:EtOAc 1:0 to 8:2) which gave nine subfractions (E1–E9). E4
582.5 mg)  was puriﬁed by CC on Sephadex LH-20 (CHCl3:MeOH
:1) to yield 4 (39.3 mg)  and 5 (43.0 mg). F (1.2 g) was fractionated
y Sephadex LH-20 CC (CHCl3:MeOH 1:1) yielding six subfrac-
ions (F1–F6). Compound 10 (3.3 mg)  was obtained pure from F5
53.0 mg). G (485.0 mg)  and H (789.0 mg)  were fractionated by
ephadex LH-20 CC (CHCl3:MeOH 1:1) to yield eleven (G1–G11)
nd ﬁve (H1–H5) subfractions, respectively. Compound 2 (9.0 mg)
as obtained from G8 and 3 (7.7 mg)  from G11. Sequential puriﬁ-
ation of H3 (510.0 mg)  by Sephadex LH-20 CC (CHCl3:MeOH 1:1)
nd VLC (PE:EtOAc 1:0 to 7:3) yielded 1 (26.1 mg). Puriﬁcation
f the EtOAC extract (8.0 g) by VLC (CH2Cl2:Me2CO 1:0 to 0:1)
ielded seven major fractions (A–G). C (1.4 g) was subjected to CC
n Sephadex LH-20 (MeOH) to give ﬁfteen subfractions (C1–C15),
rom which compounds 7 (6.4 mg), 11 (4.6 mg)  and 9 (4.1 mg)  were
btained pure from C10, C14 and C15, respectively. C8 and C11
ere puriﬁed by PTLC (CH2Cl2:Me2CO 8:2) to give 8 (3.3 mg)  and 6
5.2 mg).
2-Oxo-phytodienoic acid (1)
Colorless oil; 1H (400 MHz, C6D6) ıH 2.14 (H-2, 2H, t, 7.4 Hz), 1.50
H-3, 2H, tt, 7, 7 Hz), 1.10 (H-4, 2H, m),  1.06 (H-5, 2H, m),  1.06 (H-6,
H, m),  1.13 (H-7, 2H, m),  1.06 (H-8, 2H, m),  2.26 (H-9, 1H, m),  6.65
H-10, 1H, dd, 5.8, 2.6 Hz), 6.00 (H-11, 1H, dd, 5.8, 2.2 Hz), 1.85 (H-
3, 1H, ddd, 7.8, 4.5, 2.2 Hz), 2.50 (H-14a, H, m),  2.34 (H-14b, 1H, m),
.33 (H-15, 1H, dtt, 11, 7, 1 Hz), 5.24 (H-16, 1H, dtt, 11, 7, 1 Hz), 1.97
H-17, 2H, ddq, 7, 7, 1 Hz), 0.89 (H-18, 3H, t, 7.5 Hz); 13C (100 MHz,
6D6) ıc 179.9 (C-1), 34.1 (C-2), 24.9 (C-3), 29.2 (C-4), 29.7 (C-5),
7.5 (C-6), 29.3 (C-7), 34.5 (C-8), 46.9 (C-9), 166.1 (C-10), 133.1
C-11), 209.8 (C-12), 51.5 (C-13), 28.5 (C-14), 125.9 (C-15), 133.8
C-16), 20.9 (C-17), 14.4 (C-18); HR-ESI-MS m/z  293.2148 [M+H]+
caldc. for C18H29O3 293.2117); [D20] +60.7 (c 0.89, CDCl3).
ersicogenin (2)
Colorless oil; 1H (400 MHz, C6D6) ıH 4.70 (H-2, 1H, dd, 12.8,.1 Hz), 2.50 (H-3a, 1H, dd, 17.1, 12.8 Hz), 2.30 (H-3b, 1H, dd, 17.1,
.1 Hz), 6.21 (H-6, 1H, d, 2.3 Hz), 6.08 (H-8, 1H, d, 2.3 Hz), 6.62 (H-
′, 1H, d, 2.1 Hz), 6.35 (H-5′, 1H, d, 8.4 Hz), 7.03 (H-6′, 1H, dd, 8.4,
.1 Hz), 3.09 (OMe-7, 3H, s), 3.08 (OMe-4′, 3H, s), 12.84 (OH-5, 1H, Farmacognosia 26 (2016) 180–183 181
brs), 5.47 (OH-3′, 1H, s); 13C (100 MHz, C6D6) ıc 79.0 (C-2), 43.4
(C-3), 196.2 (C-4), 165.2 (C-5), 95.3 (C-6), 168.3 (C-7), 94.5 (C-8),
163.3 (C-9), 103.8 (C-10), 132.5 (C-1′), 113.3 (C-2′), 146.5 (C-3′),
147.0 (C-4′), 110.1 (C-5′), 118.0 (C-6′), 55.1 (OMe-7), 55.3 (OMe-4′);
HR-ESI-MS m/z 317.1046 [M+H]+ (caldc. for C17H17O6 317.1025).
Eriodictyol 3′,4′,7-trimethyl ether (3)
Colorless oil; 1H (400 MHz, C6D6) ıH 4.76 (H-2, 1H, dd, 13.1,
2.9 Hz), 2.62 (H-3a, 1H, dd, 17.1, 13.1 Hz), 2.39 (H-3b, 1H, dd, 17.1,
2.9 Hz), 6.25 (H-6, 1H, d, 2.2 Hz), 6.16 (H-8, 1H, d, 2.2 Hz), 6.69 (H-2′,
1H, d, 2 Hz), 6.52 (H-5′, 1H, d, 8.8 Hz), 6.68 (H-6′, 1H, dd, 9, 2 Hz), 3.07
(OMe-7, 3H, s), 3.36 (OMe-4′, 3H, s), 3.40 (OMe-5′, 3H, s), 12.91 (OH-
5, 1H, brs); 13C (100 MHz, C6D6) ıc 79.7 (C-2), 43.9 (C-3), 196.6 (C-4),
165.7 (C-5), 95.6 (C-6), 168.6 (C-7), 94.9 (C-8), 163.7 (C-9), 104.2
(C-10), 131.8 (C-1′), 111.0 (C-2′), 150.8 (C-3′), 150.6 (C-4′), 112.2
(C-5′), 119.4 (C-6′), 55.4 (OMe-7), 55.9 (OMe-4′), 55.9 (OMe-5′);
HR-ESI-MS m/z 331.1207 [M+H]+ (caldc. for C18H19O6 331.1182).
Onopordin (7)
Yellow powder; 1H (500 MHz, Acetone-d6) ıH 6.58 (H-3, 1H, s),
6.60 (H-6, 1H, s), 7.50 (H-2′, 1H, d, 2.2 Hz), 6.99 (H-5′, 1H, d, 8.3 Hz),
7.47 (H-6′, 1H, dd, 8.3, 2.2 Hz), 3.87 (OMe-8, 3H, s), 12.25 (OH-5, 1H,
brs); 13C (125 MHz, acetone-d6) ıc 165.4 (C-2), 103.8 (C-3), 183.6
(C-4), 157.7 (C-5), 94.8 (C-6), 154.0 (C-7), 132.2 (C-8), 154.1 (C-9),
105.8 (C-10), 123.9 (C-1′), 114.2 (C-2′), 146.6 (C-3′), 150.3 (C-4′),
116.7 (C-5′), 120.2 (C-6′), 60.8 (OMe-8); HR-ESI-MS m/z  331.0685
[M+H]+ (caldc. for C16H13O7 317.0661).
5,8,4′-Trihydroxy-7,3′-dimethoxyﬂavone (8)
Yellow powder; 1H (500 MHz, acetone-d6) ıH 6.71 (H-3, 1H, s),
6.64 (H-6, 1H, s), 7.65 (H-2′, 1H, d, 2.0 Hz), 7.01 (H-5′, 1H, d, 8.3 Hz),
7.62 (H-6′, 1H, dd, 8.3, 2.0 Hz), 3.87 (OMe-7, 3H, s), 3.99 (OMe-3′, 3H,
s), 13.25 (OH-5, 1H, brs); 13C (125 MHz, acetone-d6) ıc 165.4 (C-2),
103.9 (C-3), 183.7 (C-4), 157.6 (C-5), 94.8 (C-6), 132.1 (C-7), 153.9
(C-8), 157.0 (C-9), 105.8 (C-10), 123.7 (C-1′), 110.5 (C-2′), 148.9
(C-3′), 151.5 (C-4′), 116.4 (C-5′), 121.4 (C-6′), 60.7 (OMe-7), 56.6
(OMe-3′); HR-ESI-MS m/z 331.0826 [M+H]+ (caldc. for C17H15O7
331.0818).
Quercetin (9)
Yellow powder; 1H (500 MHz, Acetone-d6) ıH 6.26 (H-6, 1H, d,
2.0 Hz), 6.53 (H-8, 1H, d, 2.0 Hz), 7.83 (H-2′, 1H, d, 2.2 Hz), 6.99 (H-
5′, 1H, d, 8.5 Hz), 7.69 (H-6′, 1H, dd, 8.5, 2.2 Hz), 12.17 (OH-5, 1H,
brs); 13C (125 MHz, acetone-d6) ıc 164.9 (C-2), 136.7 (C-3), 176.6
(C-4), 162.3 (C-5), 99.1(C-6), 146.9 (C-7), 94.4 (C-8), 157.8 (C-9),
104.2 (C-10), 123.8 (C-1′), 115.8 (C-2′), 145.8 (C-3′), 148.3 (C-4′),
116.3 (C-5′), 121.5 (C-6′); HR-ESI-MS m/z 303.0546 [M+H]+ (caldc.
for C15H11O7 303.0505).
Leishmanicidal detection assay
The antileishmanial assay was  performed using a colorimet-
ric method-XXT (Salamanca et al., 2008). Brieﬂy, the activity was
measured in vitro on cultures of the Leishmania parasite in the
promastigote forms, of complex L. amazonensis (clon 1: Lma,
MHOM/BR/76/LTB-012) and complex L. braziliensis (strand M2904
C192 RJA) that were cultivated at 26 ◦C in Schneider medium (pH
6.8) supplemented with inactivated (by heating to 56 ◦C for 30 min)
bovine calf serum (10%). Parasites in logarithmic phase of growth,
at a concentration of 1 × 106 parasites/ml, were seeded in the wells
of 96-well plates. Solutions of compounds to be assessed at con-
centration range of 0.09–100 g/ml were added. DMSO (1%) and
amphotericin B (0.5 g/ml) were used as negative and positive con-
trols during the evaluations. All assays were performed in triplicate
and the micro well plates were incubated for 72 h at 26 ◦C. After
incubation, a solution of XTT (1 mg/ml) in PBS (pH 7.0 at 37 ◦C)
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Table 1
In vitro leishmanicidal activity on promastigote forms of Leishmania ssp.
IC50 (g/ml)a
L. amazonensis L. braziliensis
EtOH extract 6.0 ± 0.2 4.9 ± 1.2
Hexane fraction 6.1 ± 1.3 1.3 ± 0.3
EtOAc fraction 9.9 ± 0.5 5.3 ± 1.0
1  0.60 ± 0.1 (2.0 M) 0.20 ± 0.01 (0.68 M)
2  >100 90 ± 4.2 (285 M)
3 >100 > 100
7  22 ± 4.2 (70 M) 16 ± 0.46 (51 M)
8 14 ± 1.81 (42 M)  2.7 ± 0.2 (8.2 M)
9 20 ± 0.77 (66 M) 41  ± 2.7 (136 M)
Controlb 0.21 ± 0.06 (0.23 M) 0.08 ± 0.04 (0.087 M)82 E.M. Maldonado et al. / Revista Brasil
ith PMS  (Sigma–Aldrich, 0.06 mg/ml) was added (50 l/well), and
he plates were kept at 26 ◦C for another 4 h. The optical density
f each well was determined with a StatFax (Model 2100 series
late reader) at 450 nm,  and the IC50 values were calculated using
icrosoft’s Excel 2000 program.
esults and discussion
As described in the Experimental part of the crude ethanol
xtract after liquid–liquid partition yielded the hexane and ethyl
cetate fractions, from which the eleven compounds were iso-
ated and identiﬁed as: 12-oxo-phytodienoic acid (1) (Bohlmann
t al., 1983), persicogenin (2) (Pisutthanan et al., 2006), eri-
dictyol 3′,4′,7-trimethyl ether (3) (Fernandez et al., 1988),
hytol (4) (Hasan et al., 1991), spathulenol (5) (Vieira et al.,
013), 4-hydroxycinnamic acid (6) (Pan and Lundgren, 1995),
nopordin (7) (Reynaud and Raynaud, 1984), 5,8,4′-trihydroxy-
,3′-dimethoxyﬂavone (8) (Whalen and Mabry, 1979), quercetin
9) (Slowing et al., 1994), jaceosidin (10) (Ulubelen et al., 1979),
nd 8-hydroxyluteolin (11) (Taskova et al., 2008). The presence of
erpenes (4 and 5) and ﬂavonoids (7–11) in this species is in agree-
ent with previous studies of the genus, however, this is the ﬁrst
eport of the isolation of a cyclopentenone fatty acid (1) and the
avanones (2 and 3) from a Lantana species. A large number of sec-
ndary metabolites have been reported from the genus Lantana,
nd this has been excellently reviewed by Sousa and Costa (2012).
The structures of all isolated compounds were elucidated by a
ombination of high resolution mass spectrometry and high ﬁeld
MR spectroscopy. For all compounds COSY, NOESY, HMQC and
MBC 2D NMR  spectra were recorded and analyzed. In the case
hat the NMR  data previously was reported in the same solvent,
he comparison with the published data was also used to identify
he compounds.
Phytooxylipins (Blee, 1998) may  possess potent phytohormone
ctivities (Böttcher and Pollmann, 2009; Pollmann, 2009). They
re derived from oxidized C16 and C18 fatty acid precursors that
re abundant in the cellular membranes of higher plants (Gfeller
t al., 2010), by the octadecanoid pathway (Mithöfer et al., 2004).
hytooxylipins play an important role in plant response to vari-
us environmental stress conditions, and recently it was shown
hat 12-oxo-phytodienoic acid (1) inhibits the proliferation of
uman breast cancer cells by targeting cyclin D1 (Altiok et al.,
008). Flavonoids are the largest group of natural phenolic com-
ounds in higher plants, and many studies have shown that theya Data are expressed as mean standard deviation of three determinations.
b Amphotericin B was  used as positive control.
exhibit a broad range of biological activities. Examples are anti-
inﬂammatory, antitumor, antibacterial, antileishmanial and free
radical scavenging activities (Grecco et al., 2010; Mittra et al., 2000;
Samuelsson and Bohlin, 2010).
The hexane and ethyl acetate extracts of L. balansae both pos-
sessed activity toward the promastigotes of L. amazonensis and L.
braziliensis, with IC50 values between 1 and 10 g/ml (see Table 1
for details). Due to limited testing capacity we decided to evalu-
ate the antileishmanial activity of a selection of the compounds
obtained from these extracts, compounds 1–3 and 7–9, and the
results are presented in Table 1. The most potent compound was
found to be 1. Although it is less potent compared to the pos-
itive control amphotericin B, the antileishmanial activity of 1
is nevertheless interesting with the IC50 values 2.0 M toward
L. amazonensis and 0.68 M toward L. braziliensis. The cyclopen-
tenone moiety of 1 possessing an ,-unsaturated carbonyl group
may  be important for its activity, as Michael acceptors are known to
be important for a number of biological activities (Ghantous et al.,
2010). The ﬂavanones 2 and 3 were less active among the tested
ﬂavonoids, while the ﬂavones 7 and 8 as well as ﬂavonol 9 show
antileishmanial activity although they are obviously much less
potent compared to the positive control. This ﬁnding is in agree-
ment with the previously reported comparison of the activities of
naringenin, eriodictyol, and (+)-taxifolin with those of the corre-
sponding unsaturated derivatives apigenin, luteolin, and quercetin
(Tasdemir et al., 2006). The general difference between ﬂavanones
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nd ﬂavones/ﬂavonols is the lack of the C-2/C-3 double bond in the
ormer, affecting both the molecular form as well as the conjuga-
ion. However, without detailed information about the mechanism
f action it is difﬁcult to rationalize any SAR’s. Compound 8 is
lightly more potent compared to 7 and 9, especially toward L.
raziliensis. Of the three, 8 is the most lipophilic which may  be
mportant for its ability to reach the target. 3-Methoxyquercitin
as previously been shown to be more potent toward promastigote
orms of L. amazonensis than quercetin (Taleb-Contini et al., 2004),
o this appears to be a trend. The in vitro and in vivo antileishmanial
ctivity of quercetin (9) has been extensively study, and the results
resented here are in agreement with previous data (da Silva et al.,
012).
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